Back to top

Gilead price target lowered to $166 from $168 at Morgan Stanley

Morgan Stanley lowered the firm’s price target on Gilead (GILD) to $166 from $168 and keeps an Overweight rating on the shares. Biotech could benef...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Gilead Sciences, Inc. (GILD)

General Mills, Inc. (GIS)